The PD-L1 Biomarker Testing Market is witnessing significant advancements, playing a pivotal role in the landscape of cancer diagnostics and treatment. As a crucial aspect of immuno-oncology, PD-L1 biomarker testing helps identify the expression levels of PD-L1 in tumor cells, guiding therapeutic decisions for immune checkpoint inhibitors. The PD-L1 biomarker testing market is projected to be valued …
Category Archives: Healthcare Trends
Knee Hyaluronic Acid Injections Market on Track to Reach US$ 3.40 Billion by 2033-FMI Projection
The Localized Temperature Therapy Products Market is witnessing substantial growth, driven by a confluence of technological advancements and a growing focus on non-invasive therapeutic solutions. These products, designed to provide targeted temperature management for various medical conditions, are gaining prominence across healthcare settings.Approximately US$ 2.09 billion was generated by knee hyaluronic acid injection market in 2023, as …
Global Weight Loss and Obesity Management Industry is expected to reach a value of US$ 4.99 Billion by 2028, based on the FMI Study
The global weight loss and obesity management industry size is expected to have a net worth of US$ 3.68 billion in 2022 and to grow at a CAGR of 5.2% to reach US$ 4.99 billion by value by 2028. One of the most urgent health issues of our time is being addressed by the weight …
Global 3D Cell Culture Industry is on track to achieve US$ 3 Billion by 2033 with a 9% CAGR, as projected by FMI
In a significant stride towards advancing biomedical research and drug discovery, the global 3D cell culture industry size is projected to witness exponential growth, surging from US$ 1.26 billion in 2023 to a staggering US$ 3 billion by 2033. This dynamic trajectory reflects a remarkable Compound Annual Growth Rate (CAGR) of 9% during the forecast …
Global Psoriatic Arthritis (PsA) Treatment Industry to reach US$ 15.6 Billion by 2028, driven by innovation and a commitment to patient care | FMI
In 2022, the psoriatic arthritis (PsA) treatment industry size is expected to generate sales of more than US$ 10.3 billion. By 2028, the market size is anticipated to reach US$ 15.6 billion, growing at a strong 7.1% CAGR. Furthermore, small molecule targeted therapies have also emerged as a valuable addition to the treatment arsenal. Janus …
Global Onychomycosis Treatment Market is poised for growth expected to reach US$ 10,608.8 million by 2033, according to FMI
In 2023, it is anticipated that the global onychomycosis treatment market will be valued US$ 4,738.3 million. The market for onychomycosis treatments is anticipated to grow at a CAGR of 8.4% from 2023 to 2033 and reach a value of US$ 10,608.8 million. The market is expanding as a result of the rising incidence of …
Global Hypoparathyroidism Treatment Market growing to approximately US$ 1,767.4 Million by 2033, driven by Patient-Centered Care values, according to FMI
The global hypoparathyroidism treatment market is poised for significant growth, according to a comprehensive market analysis conducted by Future Market Insights. The market, valued at US$ 777.4 million in 2022, is projected to reach an estimated US$ 841.9 million by the end of 2023. This rapid expansion is forecasted to continue at a steady Compound …
Global Hydrocephalus Shunt Market is anticipated to surge to an estimated US$ 692.25 million by 2034, According to FMI Report Analysis
Future Market Insights, a leading provider of industry analysis, has unveiled promising projections for the Global Hydrocephalus Shunt Industry in its latest report. According to the analysis, the industry is poised for substantial growth, with an estimated size of US$ 546.09 million in 2024. Prognosticating a slow-pace CAGR of 2.40% over the forecast period, the …
Global Endodontics and Orthodontics Industry is poised for a 5.3% CAGR growth until 2032, owing to the surging demand for dental treatments, as per FMI
The global endodontics and orthodontics industry has been steadily rising and is forecasted to surge at a Compounded Annual Growth Rate (CAGR) of 5.3% through 2022 to 2032, with current market sales expected to reach a remarkable US$ 5.09 billion by 2022. The convergence of technological advancements, evolving patient preferences, and an increased emphasis on …
Global Oxycodone Industry is expected to achieve CAGR of 5.7% by 2033, propelled by the increasing demand for pain management solutions, as indicated by FMI
The global oxycodone market is predicted by Future Market Insight to reach an astounding US$ 8.92 billion valuation by 2033, with a CAGR of 5.7%. This anticipated expansion would be a significant boost from its projected value of US$ 5.11 billion in 2023. During the forecast period, the market revenue growth is anticipated to be …